02:16:46 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2025-02-14 Bokslutskommuniké 2024
2024-11-14 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-30 Årsstämma 2024
2024-05-17 Kvartalsrapport 2024-Q1
2024-03-01 X-dag ordinarie utdelning CSMED 0.00 DKK
2024-02-14 Bokslutskommuniké 2023
2023-12-15 X-dag ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma 2023
2023-02-10 X-dag ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 X-dag ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021


ListaSpotlight DK
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2023-07-18 08:00:00

CS MEDICA ("CS MEDICA" or the "Company") hereby releases its Q3 report for the period April - June 2023. Highlights of the period will be presented at a live-streamed conference call on Tuesday the 8nd of August at 10 AM CET. The Q3 report is available as an attached document to this press release and on the Company's website (www.cs-medica.com). Below is a summary of the report.

Performance highlights
  • In this third quarter of 2022/2023 (April - June 2023), CS MEDICA delivered net sales of tDKK 673 (1 107) and an order intake of mDKK 8.4 in Q3, which accumulates to mDKK 11,3 year-to-date.  Due to financial limitations on production initiation; product delivery and invoicing have been delayed. Consequently, the net sales goal for 2022/2023 is decreased to mDKK 1.
  • Operating profit for the first quarter amounted to tDKK -4.656, compared to tDKK -5.442 last year.
  • Cash and Cash equivalents at the end of the third Quarter of 2022/2023, total tDKK -350 (1.826) are subsequently reinforced through prepaid short-term sales and the factoring agreement with Svea. The company is currently working on different funding scenarios for its short-term funding to secure liquidity in the day-to-day operation.
  • The long-term funding is attained by the company's Investment Agreement with RongShi, with a cash capital increase (direct issue) at a price of DKK 28.13. The direct issue amounts to mDKK 60 corresponding to 14.76% of CS MEDICA 's outstanding shares on a non-diluted. 
  • At the end of the period, CS MEDICA's equity/asset ratio was 56% (64%).


Significant events during the third quarter (April - June 2023)Significant events after the period

Live streamed conference following the Q3 2022/2023 Report

On Tuesday 8 August 2023 at 10:00 CEST, CS MEDICA will host a Q3 2023 web conference. The web conference will start with a presentation from the management team commenting on the Q3 2022/2023 report, followed by a Q&A session where the management team will answer questions from investors. The Q&A is already open, meaning that you can already now submit your questions and vote for the best questions submitted by other investors. CS MEDICA has made this solution, operated by Stokk.io, available to make sure all interested can participate with their questions even though they may not be able to attend the event live. You will afterward be able to find all answers in the uploaded recording and transcript. The web conference will be held in English.

Please register, submit questions now or during the live presentation and vote for the best questions at the following link >> (https://stokk.io/app/event/91/q3-2023-presentation/).

Date and time
Tuesday 8[th] of August, 2023, from 10:00 - 10:30 PM CET

Sign up for conference
Live conference sign-up link >>. (https://stokk.io/app/event/91/q3-2023-presentation/)